SARS News and Research

RSS

Study reveals immune responses to SARS-CoV-2 peptides in COVID-19 convalescent patients

A new study aimed to demonstrate the reactivity of COVID-19 serum obtained from patients in Tatarstan, Russia with S and N peptides that were previously identified as immunogenic.

9 May 2022

Study investigates the cause of lymphopenia as seen in COVID-19 patients

Researchers explored the underlying mechanism resulting in thymic atrophy and subsequent lymphopenia in COVID-19 patients.

9 May 2022

COVID-19 booster or additional primary vaccination dose against SARS-CoV-2 Omicron in nursing home occupants

A recent study assessed the efficacy of SARS-CoV-2 primary series vaccination, additional initial dose, or booster shot against the SARS-CoV-2 Omicron infection in the nursing home.

9 May 2022

The potential impact of oral vaccination against COVID-19 on transmission to naïve individuals studied in a hamster infection model

A recent article published in Science Translational Medicine demonstrated that mucosally delivered adenovirus type 5 (Ad5)-based COVID-19 vaccination minimized COVID-19 transmission and severity.

9 May 2022

Diagnostic performance of monocyte distribution width and other leukocyte parameters for SARS-CoV-2 and influenza infection

Researchers used a novel diagnostic screen, monocyte distribution width for SARS-CoV-2 and influenza infection.

9 May 2022

Effectiveness of BNT162b2 third dose against Omicron-associated severe disease

Researchers analyzed the effectiveness of the SARS-CoV-2 BNT162b2 third vaccine dose against SARS-CoV-2 Omicron-induced severe infection nearly seven months post-vaccination.

9 May 2022

Transmission of infectious SARS-CoV-2 via fomites is possible but unlikely to occur in real-life scenarios, study concludes

Researchers have been investigating the role of fomites in SARS-CoV-2 transmission.

9 May 2022

Evidence of croup associated with SARS-CoV-2

A new study published in the Journal of Pediatric Infectious Diseases Society aimed to characterize the clinical features of SARS-CoV-2-associated croup among children presenting to the ED during the phase when Omicron variant transmission was high.

9 May 2022

Using PCR-based genotyping to detect SARS-CoV-2 delta-omicron coinfection

In a recently published ‘Letter to the Editor’ in the journal Microbiology Spectrum, scientists have described the procedure of polymerase chain reaction (PCR)-based genotyping in identifying delta-omicron coinfection in clinical samples.

9 May 2022

Benefit from convalescent plasma shown in COVID outpatient trial

Researchers have conducted a double-blind, multicentre, randomized, controlled trial, which is known as Convalescent Plasma to Limit SARS-CoV-2 Associated Complications Study to evaluate if early COVID-19 plasma treatment could reduce disease progression and, thereby, reduce hospitalization rate.

9 May 2022

COVID-19 mortality among elderly may be due to genetically predetermined limit on the immune system

Your immune system's ability to combat COVID-19, like any infection, largely depends on its ability to replicate the immune cells effective at destroying the SARS-CoV-2 virus that causes the disease.

9 May 2022

ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

A new study published in the New England Journal of Medicine has discussed the efficacy and safety profile of the ZF2001 vaccine in adults, based on a randomized, placebo-controlled, multinational, double-blind phase 3 trial.

9 May 2022

Approximately 13% of hospitalized COVID patients have serious neurologic symptoms

In a recent study in the journal Critical Care Explorations, the Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry was used to record significant neurologic signs of SARS-CoV-2 infection, as well as prehospital risk factors and outcomes.

9 May 2022

Infection with SARS-CoV-2 results in antibodies against common colds

A study published in the journal Science Advances uses electron microscopy-based polyclonal epitope mapping (EMPEM) methodology to elucidate the spike epitopes of β-HCoV targeted by preexisting serum antibodies and compares them to the epitopes targeted by antibodies elicited by SARS-CoV-2 infection using electron microscopy-based polyclonal epitope mapping (EMPEM) methodology.

8 May 2022

Pathogenicity and transmissibility of SARS-CoV-2-related pangolin coronavirus

Researchers observed that pangolin coronaviruses related to SARS-CoV-2 share similar pathogenicity and transmissibility in hamsters.

6 May 2022

Study reveals why some lungs are protected against COVID

COVID-19 vaccines have saved at least a million lives in the United States alone, but for many people, a lingering fear remains: if-;or when-;they get hit by the coronavirus, just how bad will it be? Will they breeze through with little more than a sore throat-;or will it saddle them with long-term complications, perhaps even push them to the brink of death?

6 May 2022

SARS News and Research

Study reveals immune responses to SARS-CoV-2 peptides in COVID-19 convalescent patients

Study investigates the cause of lymphopenia as seen in COVID-19 patients

COVID-19 booster or additional primary vaccination dose against SARS-CoV-2 Omicron in nursing home occupants

The potential impact of oral vaccination against COVID-19 on transmission to naïve individuals studied in a hamster infection model

Diagnostic performance of monocyte distribution width and other leukocyte parameters for SARS-CoV-2 and influenza infection

Effectiveness of BNT162b2 third dose against Omicron-associated severe disease

Transmission of infectious SARS-CoV-2 via fomites is possible but unlikely to occur in real-life scenarios, study concludes

Evidence of croup associated with SARS-CoV-2

Using PCR-based genotyping to detect SARS-CoV-2 delta-omicron coinfection

Benefit from convalescent plasma shown in COVID outpatient trial

COVID-19 mortality among elderly may be due to genetically predetermined limit on the immune system

ZF2001 vaccine safe and effective against symptomatic and severe-to-critical COVID

Approximately 13% of hospitalized COVID patients have serious neurologic symptoms

Infection with SARS-CoV-2 results in antibodies against common colds

Pathogenicity and transmissibility of SARS-CoV-2-related pangolin coronavirus

Study reveals why some lungs are protected against COVID

Potential antiviral targets in SARS-CoV-2

Positive effects of altered maternal care during COVID-19 in Australia

Scientists explore immunopathology of COVID-19

Impact of COVID-19 during pregnancy on development of fetal auditory system

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News